Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 19, 2014

Drug Name Review Type Class Manufacturer
Sovaldi New Drug Initial Review Hepatitis C Gilead
Otrexup New Drug Initial Review DMARD Antares
Brintellix New Drug Initial Review Antidepressant Takeda
Olysio New Drug Initial Review Hepatitis C Johnson & Johnson
Natroba New Drug Appeal Head Lice ParaPro
Quillivant XR New Drug Appeal Stimulant/ADHD Pfizer
Linzess New Drug Appeal Guanylate Cyclase-C Agonist Forest
TOBI Podhaler New Drug Appeal Aminoglycoside Novartis
Abilify Maintena PDL Appeal Atypical Antipsychotic Otsuka
Onglyza PDL Appeal DPP-4 Inhibitor AstraZeneca